Over the past six years, we’ve helped position Australia as a global leader in psychedelic-assisted therapies. From rescheduling MDMA and psilocybin to training over 500 clinicians and supporting groundbreaking research, our work is driving real change for mental health. Here are some of the milestones we’ve reached so far.
Key Achievements
- Successful Rescheduling of Medicines
Our advocacy led to the rescheduling of psilocybin and MDMA, making them legally prescribable by psychiatrists across Australia for treatment-resistant depression (psilocybin) and PTSD (MDMA). This milestone has positioned Australia and our charity as global leaders in the clinical application of psychedelic-assisted therapies. We are now actively working to extend rescheduling to palliative care, enabling therapeutic use for people with terminal illness to address depression and anxiety.
- Training Over 500 Clinicians
Including psychiatrists, GPs, psychologists, psychotherapists and more, through our Certificate in Psychedelic-Assisted Therapies (CPAT™) which is regularly referred to as the world’s best.
- Largest Importer of Medicines
We are the largest importer of these medicines into Australia, ensuring reliable access for therapeutic use.
- Launching New Clinics and providing Support for Clinic Infrastructure
We are actively launching and supporting new clinics. We provide “how-to” guides and operational resources to new clinics and are developing clinic software systems to enhance patient experience and reduce costs.
- Government Engagement and Policy Change
Advocating at Federal, State, and Territory levels for more efficient and less costly regulatory processes. This has led directly to more streamlined regulatory approaches in both Victoria and New South Wales.
- Research and Data Infrastructure
– Funded clinical trials for OCD and other mental illnesses
– Supported and funded an ANU-led Real World Evidence Registry for psychedelic-assisted therapies, the first of its kind globally
- Funding Milestone
Our advocacy directly led to the largest-ever Australian Government grant for psychedelic research: $15 million awarded in 2021 through the Medical Research Future Fund (the largest government grant globally to supported research into psychedelic assisted therapies for mental health treatments.
- Financial Assistance for Patients
Established and operate the Patient Support Fund, providing over $100,000 in financial support for 10 patients to undergo psychedelic-assisted therapies in its first year.
- Insurance and Reimbursement Advocacy
Presenting to private insurers and governments to encourage patient subsidies for psychedelic-assisted therapies.
Other Achievements
Training & Education
- Educated over 3500 people across all programs (workshops, CPAT™, online courses, Global Summit)
- Participants from every Australian state and 20+ other countries
- Launched Australia’s first accredited psychedelic training course (CPAT™)
- Delivered 230+ webinars and a 56-episode podcast series featuring global leaders
- Developed a BLOG, extensive education resources, and partnered with universities to share them
Public Awareness & Engagement
- Website: 551,000+ page views
- YouTube: 684,000+ views, 5371+ subscribers
- Social Media: 101,700+ followers
- Mailing List: 47,000+ subscribers (within a broader 72,000+ person engaged database)
- National Chapters Network: 30+ chapters, 2200+ members
- Events: Special events and documentary screenings with 42,000+ participants
- Media: Featured in 350+ major media outlets
- Published Australia’s first Book of Psychedelic Healing Stories
- Sold-out launch event with Professor David Nutt at the University of Melbourne
Sector Leadership & Stakeholder Engagement
- Established a world-class Board, Ambassador network, Advisory Panel, Young Leaders, and Lived Experience Panels
- Built strong ties with key stakeholders across academia, health, and regulatory sectors
- Developing a gold-standard National Care Program with clinical partners
Research, Events & Policy
- Supported numerous clinical trials including OCD and healthy volunteer studies
- Collaborating on medicine manufacturing in Australia
- Hosted the Southern Hemisphere’s largest psychedelic summit (2021), featuring: 1000+ participants, 30+ global speakers, 180+ partner organisations and 80,000+ website visits
- Made key submissions to government inquiries and commissions, influencing mental health policy nationwide
Support our work and help make psychedelic-assisted therapies accessible to all Australians who need them.
